Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New System May Enable at-Home Testing for Sleep Disorders

By LabMedica International staff writers
Posted on 06 Oct 2015
Sleep analysis experts have developed a noninvasive system based on audio recordings for breath sound analysis (BSA) that may help simplify diagnosis of sleep disorders such as obstructive sleep apnea (OSA), at far more convenience and lower cost than polysomnography (PSG), resulting in increased willingness for patients to undergo testing.

"We’ve developed a non-contact, BSA algorithm that provides a reliable estimation of whole-night sleep evaluation for detection of sleep quality, snoring severity, and OSA. More...
It has the potential to reduce the cost and management of sleep disorders,” said study leader Yaniv Zigel, PhD, Dept. Biomedical Engineering, Ben Gurion University (Be'er Sheva, Israel).

PSG requires a full night sleep-center stay and patients are connected to numerous electrodes and sensors to acquire signals and data from electroencephalography (EEG), electrooculography (EOG), electromyography (EMG), and electrocardiography (ECG) tests. The data is processed and visually examined or mathematically transformed manually in order to reveal insights about sleep/wake states and many aspects of physiology. “This procedure is time-consuming, tedious, and costly due to complexity and the need for technical expertise; the market is begging for a better solution,” said first author Eliran Dafna, BGU PhD student.

In the design and validation studies, whole-night breathing sounds were measured from 150 patients using both ambient microphones and PSG simultaneously. The system was trained in a design study on 80 subjects and a validation study was blindly performed on the additional 70 subjects. A set of acoustic features quantifying breathing patterns was developed to distinguish between sleep and wake segments. Sleep quality parameters were calculated based on the sleep/wake classifications and compared with PSG for validity.

When comparing sleep quality parameters, there were only minor average differences between PSG and BSA. Measuring 150,000 individual time segments (epochs), the BSA epoch-by-epoch accuracy rate for the validation study was 83.3% with 92.2% sensitivity measuring sleep-as-sleep, specificity of 56.6% for awake-as-awake, and Cohen's kappa of 0.508.

“The results showed that sleep/wake activity and sleep quality parameters can be reliably estimated solely using BSA,” said coauthor and sleep expert Prof. Ariel Tarasiuk, of BGU and Soroka University Medical Center (Be'er Sheva, Israel). “This study highlights the potential of this innovative approach to measure sleep in research and clinical circumstances. Clearly, the transition of this technology to at-home sleep evaluation depends on third-party reimbursements for the use of home-study equipment.”

The study, by Dafna E et al., was published February 24, 2015, in the journal PLOS ONE.

Related Links:

Ben Gurion University 



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.